GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM, EGM Calendar - Week Ahead

Wed, 29th Apr 2015 05:14

UK AGM, EGM Calendar
Wednesday, April 29
Segro
MTI Wireless Edge
Countrywide
British American Tobacco
Aggreko
Aviva
HellermannTyton
Kennedy Wilson Europe Real Estate
EMIS
Global Invacom Group
Nichols
Admiral
Aberdeen UK Tracker Trust 
Asian Total Return Investment Company 
Devro
Fidessa Group
Lancashire Holdings
Alliance Trust
Weir Group
Polar Capital Global Financials Trust 
EP Global Opportunities Trust
London Stock Exchange Group
Thursday, April 30
Berendsen
Alkane Energy
Colt Group
Ashtead Group
James Fisher & Sons
Synthomer
Ultra Electronics Holdings
Modern Water
Schroders
Tullow Oil
Anglo Pacific
STV Group
Witan Investment Trust
LSL Property
IndigoVision
ARM Holdings
GLI Finance
International Personal Finance
Moneysupermerket.com
RIT Capital Partners
Unilever
Everyman Media Group
Fyffes
BT
H&T Group
Friday, May 1
Aer Lingus
SVG Capital
Jardine Lloyd Thompson Group
Virgin Money
Fairpoint
Electric Word
Capital & Counties Properties
RPS Group
Smurfit Kappa
Silence Therapeutics
Monday, May 4
No Events Scheduled 
Tuesday, May 5
Catlin Group
Randgold Resources
Macfarlane Group
BG Group
Burford Capital
GVC Holdings
Henderson High Income
Spirent Communications
Stratex International
Sherborne Investors
 
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 Aug 2019 18:48

Societe Generale Builds 5% Interest In Silence Therapeutics

(Alliance News) - Silence therapeutics PLC said on Thursday that French investment bank Societe Generale SA has a 5% stake in the company.It was not disclosed how many shares, if any, that

Read more
29 Jul 2019 11:43

Silence Therapeutics Appoints Mallinckrodt Executive Romano To Board

LONDON (Alliance News) - Silence Therapeutics PLC said Monday that Steven Romano has joined as non-executive director, as part of the company's collaboration and equity investment by has USD5

Read more
18 Jul 2019 13:23

Silence Therapeutics Surges As It Signs Major Deal With Mallinckrodt

(Alliance News) - New York-listed Mallinckrodt PLC has invested USD5 million into Silence Therapeutics PLC, the two announced on Thursday, as part of a collaboration worth potentially hundreds of

Read more
18 Jun 2019 16:00

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 19 JuneTarsus GroupCadongan PetroleumWhitbreadSagaN4 20

Read more
28 May 2019 13:26

Silence Therapeutics enters into collaboration with Genomics England

(Sharecast News) - Novel therapeutics developer Silence Therapeutics has entered into a collaboration with Genomics England for the investigation of novel targets involved in human disease, it announced on Tuesday.

Read more
25 Apr 2019 12:32

Silence Therapeutics Reappoints Ross As Chair; Changes Non-Execs

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday it had reappointed Iain Ross as chair of the genetic medicines firm with immediate effect, alongside the hiring of another - who as

Read more
18 Apr 2019 10:48

Silence Therapeutics Interim Finance Chief Quinn Appointed Permanently

LONDON (Alliance News) - Silence Therapeutics PLC said on Thursday Interim Chief Financial Officer Rob Quinn has been promoted to the role on a permanent basis with immediate effect.He will

Read more
18 Apr 2019 09:27

Silence Therapeutics makes Rob Quinn permanent CFO

(Sharecast News) - Biotechnology company Silence Therapeutics said it had appointed Rob Quinn to take over as its full-time chief financial officer, effective immediately.

Read more
16 Apr 2019 12:06

Silence Therapeutics Interim Chair Departs, New Head Of R&D Joins

LONDON (Alliance News) - Silence Therapeutics PLC on Tuesday reported a number of changes to its board and operational team, including its interim chair.Andy Richards has been serving as a

Read more
11 Mar 2019 10:49

Silence Therapeutics Loss Widens After Share Disposal Year Before

LONDON (Alliance News) - Silence Therapeutics PLC on Monday said its loss widened considerably in its most recent year after a gain on the disposal of its shares in Arrowhead Pharmaceuticals Inc a

Read more
11 Mar 2019 10:36

Silence Therapeutics losses widen as it progresses drug candidates

(Sharecast News) - Drug development company Silence Therapeutics announced its unaudited preliminary results for the year ended 31 December on Monday, reporting a loss after tax of £18.4m, widening form £1.6m a year earlier.

Read more
15 Jan 2019 11:20

Silence Therapeutics' Lead Candidate Drug Gets Orphan Status In Europe

LONDON (Alliance News) - Silence Therapeutics on Tuesday said its SLN124 main candidate drug has been designated as an orphan drug in Europe for the treatment of beta-thalassemia.Shares in

Read more
9 Jan 2019 10:40

Silence Therapeutics CFO steps down

(Sharecast News) - Silence Therapeutics chief financial officer David Ellam stepped down from the group with immediate effect on Wednesday.

Read more
9 Jan 2019 09:26

Silence Therapeutics Chief Financial Officer David Ellam Resigns

LONDON (Alliance News) - Silence Therapeutics PLC said Wednesday Chief Financial Officer David Ellam has resigned from the serious disease treatment firm with immediate effect.Ellam - CFO -

Read more
11 Oct 2018 13:27

US Patent Board Rejects Alnylam's Claim Against Silence Therapeutics

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday the US Patent Trial & Appeal Board rejected Alnylam Pharmaceutics Inc's petition against newly-issued Silence filed a total

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.